In one paragraphArticle in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Qintao GeDepartment of Urology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College; Qingdao Institute of Life Sciences, Fudan University, Shanghai, 200032, P.R. China.ORCID 0000-0001-5040-6699 Shengdong GeDepartment of Urology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou, 510900, China.ORCID 0000-0001-8187-9894 Zhongyuan WangDepartment of Urology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College; Qingdao Institute of Life Sciences, Fudan University, Shanghai, 200032, P.R. China.ORCID 0000-0002-0257-8450 Aihetaimujiang AnwaierDepartment of Urology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College; Qingdao Institute of Life Sciences, Fudan University, Shanghai, 200032, P.R. China.ORCID 0000-0002-0859-5171 Jiahe LuDepartment of Urology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College; Qingdao Institute of Life Sciences, Fudan University, Shanghai, 200032, P.R. China.ORCID 0000-0002-3555-1991 Xi TianDepartment of Urology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College; Qingdao Institute of Life Sciences, Fudan University, Shanghai, 200032, P.R. China.ORCID 0000-0003-1965-0647 Yue WangDepartment of Urology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College; Qingdao Institute of Life Sciences, Fudan University, Shanghai, 200032, P.R. China.
Jianfeng YangDepartment of Urology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, P.R. China.ORCID 0000-0002-9526-2438 Dingwei YeDepartment of Urology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College; Qingdao Institute of Life Sciences, Fudan University, Shanghai, 200032, P.R. China.ORCID 0000-0002-6761-5195 Shan-Chao ZhaoDepartment of Urology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou, 510900, China.ORCID 0000-0002-1162-8077 Wenhao XuDepartment of Urology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College; Qingdao Institute of Life Sciences, Fudan University, Shanghai, 200032, P.R. China.ORCID 0000-0002-0660-9162 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Tumor immune barriers (TIBs) are spatially organized stromal-immune niches that restrict lymphocyte entry. To explain persistent immune-checkpoint blockade (ICB) resistance in clear cell renal cell carcinoma (ccRCC), we mapped TIBs and defined a peritumoral variant built from POSTN
Indexed as
Apolipoproteins ECancer-Associated FibroblastsCarcinoma, Renal CellDrug Resistance, NeoplasmKidney NeoplasmsMacrophagesTumor-Associated MacrophagesAnimalsCell Adhesion MoleculesHumansImmune Checkpoint InhibitorsImmunotherapyMicePeriostinTransforming Growth Factor beta1Tumor MicroenvironmentApolipoproteins ECell Adhesion MoleculesImmune Checkpoint InhibitorsPeriostinPOSTN protein, humanTransforming Growth Factor beta1
Identifiers
PMID42566529
PMCPMC13450211
What Socratic holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390